Remission Is the Mission : Effects of the Implementation of Treat-To-Target in Early Rheumatioid Arthritis

doi 10.3990/1.9789036534659
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University Library/University of Twente

Related search

OP0289 Treat-To-Target in Early Rheumatoid Arthritis: Association Between Sustained Remission and Joint Damage

2017English

Treat-To-Target Concept Implementation for Evaluating Rheumatoid Arthritis Patients in Daily Practice

European Journal of Rheumatology
2019English

Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions

Rheumatology and Therapy
2019English

OP0226 Sustained Effectiveness of Methotrexate With Step-Down Glucocorticoid Remission Induction (Cobra Slim) for Early Rheumatoid Arthritis in a Treat-To- Target Setting: 2-Year Results of the Carera Trial

2017English

Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of the TRACTION Trial Phase II

Arthritis Care and Research
Rheumatology
2018English

THU0085 Time to Remission and the Achievement of Sustained Remission in Patients With Early Rheumatoid Arthritis: Site Variation Analysis in Therapeutic Strategy From the Canadian Early Arthritis Cohort (CATCH)

2017English

Treat-To-Target in Systemic Lupus Erythematosus: The Time Is Now!

Egyptian Journal of Rheumatology and Clinical Immunology
2015English

Genital Infection in Early Pregnancy: To Treat or Not to Treat, That Is the Question

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

Application of Treat-To-Target Principles in Patients With Early Rheumatoid Arthritis in Routine Clinical Practice in Central-Eastern Europe

International Journal of Clinical Rheumatology
Rheumatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy